2017
DOI: 10.1016/j.ijscr.2017.05.025
|View full text |Cite
|
Sign up to set email alerts
|

Salvage photodynamic therapy accompanied by extended lymphadenectomy for advanced esophageal carcinoma: A case report

Abstract: HighlightsA case of esophageal cancer was treated with PDT after salvage Appleby operation.Salvage lymphadenectomy is a safer procedure than salvage esophagectomy.Salvage lymphadenectomy may be insufficient as a curative treatment.PDT is a novel promising option for control primary carcinoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 18 publications
0
1
0
Order By: Relevance
“…Over the past two decades, there was a slow but consistent understory of research and development of a large number of nanoparticles (NPs) in IBDs; NPs are polymeric fine units with at least one dimension up to 100 nm, which can be built to reach an intended target, be detected with a molecular imaging technique and further engineered to locally deploy a certain agent, with several mechanisms of activation including charge-mediated targeting, micro-environment triggered release targeting, and ligand-mediated targeting [79,80]. Nanomedicine combined with endoscopy has built up a solid background in ex vivo and in vivo preclinical settings, with minimal preliminary clinical data concerning esophageal and biliary cancers [79,81,82]; however, there is still no impact on clinical practice, in part due to safety concerns and heterogeneity of NPs, practical application, and study designs. The dual potential of NPs as drug-eluting and detectable nanovehicles represents an exciting perspective in IBD, potentially leading to dose-controlled and selective insite bioavailability of a drug or a therapeutic intervention targeting inflamed mucosa [83].…”
Section: New Techniques and Future Scenarios For Stenosis And Fibrosi...mentioning
confidence: 99%
“…Over the past two decades, there was a slow but consistent understory of research and development of a large number of nanoparticles (NPs) in IBDs; NPs are polymeric fine units with at least one dimension up to 100 nm, which can be built to reach an intended target, be detected with a molecular imaging technique and further engineered to locally deploy a certain agent, with several mechanisms of activation including charge-mediated targeting, micro-environment triggered release targeting, and ligand-mediated targeting [79,80]. Nanomedicine combined with endoscopy has built up a solid background in ex vivo and in vivo preclinical settings, with minimal preliminary clinical data concerning esophageal and biliary cancers [79,81,82]; however, there is still no impact on clinical practice, in part due to safety concerns and heterogeneity of NPs, practical application, and study designs. The dual potential of NPs as drug-eluting and detectable nanovehicles represents an exciting perspective in IBD, potentially leading to dose-controlled and selective insite bioavailability of a drug or a therapeutic intervention targeting inflamed mucosa [83].…”
Section: New Techniques and Future Scenarios For Stenosis And Fibrosi...mentioning
confidence: 99%